Male Reproductive Cancers and Infertility

Testicular cancer (TC) is not ranked as a prevalent male cancer in the world, it is the most common oncological diagnosis in the reproductive age group of patients (20–35 years). The theory behind this critical connection possibly lies in a burst of hormones typical for males reaching puberty, triggering carcinoma in situ (CIS) cells, being “innate” and having the potential to proliferate into cancer cells. Different types of TC exist, however the most common is testicular germ cell cancer (TGCC), representing about 95%, with approximately 9000 diagnoses in the United States each year. TGCCs are of two types, seminomas and non-seminomas. Each constitutes approximately 50% of TGCCs, while 15% of patients present with both types .

 

Seminomas originate in the germinal epithelium of the seminiferous tubules, where malignant cells most likely arise from primordial germ cells (PGCs) -progenitors of the gametes. Compared to other TGCCs, these tumors are generally more responsive to treatment via orchiectomy, chemotherapy or radiation. Unlike seminomas, nonseminomas represent other types of germ cell tumors, such as embryonal carcinoma, teratoma, yolksac tumor, choriocarcinoma, and are usually treated with chemotherapy due to a lower sensitivity to radiation.

 

    Related Conference of Male Reproductive Cancers and Infertility

    October 10-11, 2022

    International Conference on Women Leadership and Management

    Prague, Aland Islands
    October 13-14, 2022

    2nd World Congress on Gynecology & Obstetrics

    Tokyo, Japan
    November 07-08, 2022

    9thAsia Pacific Gynecology and Obstetrics Congress

    Singapore City, Singapore
    December 09-10, 2022

    14th International Conference on Gynecology

    Barcelona, Spain
    February 06-07, 2023

    2nd World Congress on Women Health and Gynecology

    Rome, Italy
    February 20-21, 2023

    6th Annual Congress on Polycystic Ovarian Syndrome and Fertility

    Amsterdam, Netherlands

    Male Reproductive Cancers and Infertility Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in